Ceesay Abraham
Chief Executive Officer · 30 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-14 | RAPP | Rapport Therapeutics, Inc. | Sale | 5,481 | $39.72 | $217,714.64 | filing |
| 2026-07-14 | RAPP | Rapport Therapeutics, Inc. | Sale | 2,729 | $40.57 | $110,722.08 | filing |
| 2026-06-29 | RAPP | Rapport Therapeutics, Inc. | Sale | 7,344 | $39.77 | $292,062.07 | filing |
| 2026-06-29 | RAPP | Rapport Therapeutics, Inc. | Sale | 876 | $40.34 | $35,335.65 | filing |
| 2026-05-08 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award | 1,438 | $177.62 | $255,417.56 | filing |
| 2026-02-18 | RAPP | Rapport Therapeutics, Inc. | Sale | 3,552 | $29.05 | $103,191.28 | filing |
| 2026-02-18 | RAPP | Rapport Therapeutics, Inc. | Sale | 2,983 | $29.04 | $86,639.15 | filing |
| 2026-02-18 | RAPP | Rapport Therapeutics, Inc. | Sale | 2,281 | $29.80 | $67,969.92 | filing |
| 2026-02-18 | RAPP | Rapport Therapeutics, Inc. | Sale | 2,100 | $29.80 | $62,572.65 | filing |
| 2026-01-20 | RAPP | Rapport Therapeutics, Inc. | Sale | 5,833 | $26.12 | $152,333.46 | filing |
| 2026-01-20 | RAPP | Rapport Therapeutics, Inc. | Sale | 5,083 | $26.11 | $132,737.46 | filing |
| 2025-12-17 | RAPP | Rapport Therapeutics, Inc. | Sale | 2,792 | $30.04 | $83,861.91 | filing |
| 2025-12-17 | RAPP | Rapport Therapeutics, Inc. | Sale | 2,421 | $30.04 | $72,721.51 | filing |
| 2025-12-17 | RAPP | Rapport Therapeutics, Inc. | Sale | 2,441 | $28.84 | $70,393.07 | filing |
| 2025-12-17 | RAPP | Rapport Therapeutics, Inc. | Sale | 2,147 | $28.84 | $61,924.85 | filing |
| 2025-12-17 | RAPP | Rapport Therapeutics, Inc. | Sale | 600 | $31.04 | $18,621.60 | filing |
| 2025-12-17 | RAPP | Rapport Therapeutics, Inc. | Sale | 515 | $31.04 | $15,985.39 | filing |
| 2025-11-17 | RAPP | Rapport Therapeutics, Inc. | Sale | 3,056 | $25.43 | $77,715.00 | filing |
| 2025-11-17 | RAPP | Rapport Therapeutics, Inc. | Sale | 2,841 | $25.44 | $72,266.52 | filing |
| 2025-11-17 | RAPP | Rapport Therapeutics, Inc. | Sale | 2,777 | $24.92 | $69,215.61 | filing |
| 2025-11-17 | RAPP | Rapport Therapeutics, Inc. | Sale | 2,242 | $24.91 | $55,849.79 | filing |
| 2025-10-15 | RAPP | Rapport Therapeutics, Inc. | Sale | 4,647 | $25.72 | $119,539.43 | filing |
| 2025-10-15 | RAPP | Rapport Therapeutics, Inc. | Sale | 4,328 | $25.75 | $111,428.69 | filing |
| 2025-10-15 | RAPP | Rapport Therapeutics, Inc. | Sale | 1,186 | $26.14 | $31,001.09 | filing |
| 2025-10-15 | RAPP | Rapport Therapeutics, Inc. | Sale | 755 | $26.17 | $19,759.94 | filing |
| 2025-09-17 | RAPP | Rapport Therapeutics, Inc. | Sale | 39,435 | $26.30 | $1.0M | filing |
| 2025-09-17 | RAPP | Rapport Therapeutics, Inc. | Sale | 34,885 | $26.30 | $917,541.78 | filing |
| 2025-09-17 | RAPP | Rapport Therapeutics, Inc. | Sale | 1,400 | $26.87 | $37,624.30 | filing |
| 2025-09-17 | RAPP | Rapport Therapeutics, Inc. | Sale | 700 | $27.04 | $18,930.03 | filing |
| 2025-09-04 | PCRX | Pacira BioSciences, Inc. | Sale | 2,354 | $27.19 | $64,005.26 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.